Objective:This study aimed to demonstrate a new surgical shear with an integrated energy system(Harmonic ACE^(®)+7)value by determining its effectiveness and economic outcomes compared with conventional ultrasoni...Objective:This study aimed to demonstrate a new surgical shear with an integrated energy system(Harmonic ACE^(®)+7)value by determining its effectiveness and economic outcomes compared with conventional ultrasonic shears(CUSs)in a real-world setting.Methods:This was a retrospective study of adults with prostate cancer undergoing laparoscopic radical prostatectomy with the ACE^(®)+7 shear or CUSs between August 2019 and April 2021 at Shanghai Ruijin Hospital(the headquarters and Luwan Center in China).Demographic and diagnosis information,intraoperative and postoperative clinical outcomes,and total and categorical costs were collected.Propensity score matching was performed to form the study population for each clinical group.Data were compared between the two groups using t-test and Chi-squared test.Results:The ACE^(®)+7 was associated with a lower mean number of hemostatic clips used per surgery compared with CUSs(12.8 vs.19.8,p<0.001),a moderate but not significant difference in mean postoperative drainage duration(6.6[standard deviation,SD 2.2]days vs.7.9[SD 4.1]days,p=0.082),a reduction on mean total drainage volume(275.5[SD 374.3] mL vs.492.9[SD 1495.0]mL,p=0.321),and a lower mean rate of postoperative hemostatic drug usage(16.0%vs.52.0%,p<0.001).There was no significant difference in total costs between the ACE^(®)+7 and CUS groups.Conclusion:This study provides real-world data demonstrating that the ACE^(®)+7 shear with an integrated energy system improves clinical outcomes compared with CUSs and can offer cost savings for hospitals and health systems.Using the ACE^(®)+7 during laparoscopic radical prostatectomy allows physicians to help their patients achieve better outcomes and not spend additional money.展开更多
Objective:To compare pre-and post-radical prostatectomy(RP)responses in the urinary incontinence domain of Expanded Prostate Cancer Index Composite-26(EPIC-26)in cohorts from the USA,Norway and Spain.Methods:A prospec...Objective:To compare pre-and post-radical prostatectomy(RP)responses in the urinary incontinence domain of Expanded Prostate Cancer Index Composite-26(EPIC-26)in cohorts from the USA,Norway and Spain.Methods:A prospective study of pre-and 1-year post-treatment responses in American(nZ537),Norwegian(nZ520)and Spanish(nZ111)patients,establishing the prevalence of urinary incontinence defined according to published dichotomization.Thereafter we focused on the response alternatives“occasional dribbling”,pad use and problem experience.A multivariate logistic regression analysis(significance level≤0.01)considered risk factors for“not retaining total control”.展开更多
Objective: to investigate the efficacy of amlodipine and enalapril in the treatment of elderly patients with hypertension. Methods: 64 elderly patients with hypertension admitted in our hospital from January 2019 to J...Objective: to investigate the efficacy of amlodipine and enalapril in the treatment of elderly patients with hypertension. Methods: 64 elderly patients with hypertension admitted in our hospital from January 2019 to January 2021 were strictly selected as the key objects of this study. The department randomly divided them into two groups, the observation group and the control group, with 32 cases in each group. In terms of medication treatment, amlodipine and enalapril were used in the former group of patients with hypertension, and amlodipine tablets were used in the latter group. The changes of blood pressure, clinical indicators, incidence of adverse reactions, treatment effect, changes of serum inflammatory factors, improvement of quality of life and other research data of the two groups during the medication period were balanced into the statistical software for calculation.展开更多
Urology has been on the forefront of technological advances in minimally invasive surgery, from laparoscopy to robot-assisted surgeries. As with all new technological advances in medicine, the results of new advances ...Urology has been on the forefront of technological advances in minimally invasive surgery, from laparoscopy to robot-assisted surgeries. As with all new technological advances in medicine, the results of new advances are compared to previously established gold standards. When it comes to robot-assisted urology, morbidity, oncological outcomes, and cost between the same surgeries performed in an open fashion vs with robot-assistance should be assessed. Because healthcare spending is increasingly under more scrutiny, there is debate on the cost effectiveness of robot-assisted surgeries given the high acquisition and maintenance cost of robotic systems. This articles aims to critically evaluate the cost effectiveness of robot-assisted surgeries for prostatectomies, cystectomies, and partial nephrectomies in the United States.展开更多
背景与目的:多项回顾性研究显示,寡转移性前列腺癌根治术可以提高肿瘤的局部控制率和患者的总生存受益,围手术期并发症是影响寡转移性前列腺癌患者行前列腺癌根治术的一个重要因素。该研究旨在探讨寡转移性前列腺癌患者行前列腺癌根治...背景与目的:多项回顾性研究显示,寡转移性前列腺癌根治术可以提高肿瘤的局部控制率和患者的总生存受益,围手术期并发症是影响寡转移性前列腺癌患者行前列腺癌根治术的一个重要因素。该研究旨在探讨寡转移性前列腺癌患者行前列腺癌根治术的临床初步疗效及围手术期并发症发生率和严重程度。方法:收集2015年7月—2016年1月247例前列腺癌根治术患者数据,其中寡转移性前列腺癌患者25例,局限性前列腺癌患者222例。两组均采用Clavien-Dindo手术并发症分级标准对出现并发症的患者进行分级。观察前列腺特异性抗原(prostate specific antigen,PSA)下降比例并将并发症发生率与严重程度在寡转移组和非寡转移组间进行对比分析。结果:寡转移组术后3个月时21例(84.0%)出现下降PSA,下降比例低于局限组212例(95.5%),差异有统计学意义(P<0.05)。寡转移组共6例(24.0%)患者发生术后并发症,其中严重并发症(Ⅲ度及以上)1例(4.0%),局限组共49例(22.1%)患者发生术后并发症,其中严重并发症(Ⅲ度及以上)7例(3.2%),差异无统计学意义(P>0.05)。结论:寡转移性前列腺癌患者行前列腺癌根治术治疗是安全、有效和可行的,并发症风险并非寡转移性前列腺癌患者行前列腺癌根治术的限制因素。展开更多
文摘Objective:This study aimed to demonstrate a new surgical shear with an integrated energy system(Harmonic ACE^(®)+7)value by determining its effectiveness and economic outcomes compared with conventional ultrasonic shears(CUSs)in a real-world setting.Methods:This was a retrospective study of adults with prostate cancer undergoing laparoscopic radical prostatectomy with the ACE^(®)+7 shear or CUSs between August 2019 and April 2021 at Shanghai Ruijin Hospital(the headquarters and Luwan Center in China).Demographic and diagnosis information,intraoperative and postoperative clinical outcomes,and total and categorical costs were collected.Propensity score matching was performed to form the study population for each clinical group.Data were compared between the two groups using t-test and Chi-squared test.Results:The ACE^(®)+7 was associated with a lower mean number of hemostatic clips used per surgery compared with CUSs(12.8 vs.19.8,p<0.001),a moderate but not significant difference in mean postoperative drainage duration(6.6[standard deviation,SD 2.2]days vs.7.9[SD 4.1]days,p=0.082),a reduction on mean total drainage volume(275.5[SD 374.3] mL vs.492.9[SD 1495.0]mL,p=0.321),and a lower mean rate of postoperative hemostatic drug usage(16.0%vs.52.0%,p<0.001).There was no significant difference in total costs between the ACE^(®)+7 and CUS groups.Conclusion:This study provides real-world data demonstrating that the ACE^(®)+7 shear with an integrated energy system improves clinical outcomes compared with CUSs and can offer cost savings for hospitals and health systems.Using the ACE^(®)+7 during laparoscopic radical prostatectomy allows physicians to help their patients achieve better outcomes and not spend additional money.
基金The study was funded by a grant from Health-RegionSouth. East, Norway (No. 8324).
文摘Objective:To compare pre-and post-radical prostatectomy(RP)responses in the urinary incontinence domain of Expanded Prostate Cancer Index Composite-26(EPIC-26)in cohorts from the USA,Norway and Spain.Methods:A prospective study of pre-and 1-year post-treatment responses in American(nZ537),Norwegian(nZ520)and Spanish(nZ111)patients,establishing the prevalence of urinary incontinence defined according to published dichotomization.Thereafter we focused on the response alternatives“occasional dribbling”,pad use and problem experience.A multivariate logistic regression analysis(significance level≤0.01)considered risk factors for“not retaining total control”.
文摘Objective: to investigate the efficacy of amlodipine and enalapril in the treatment of elderly patients with hypertension. Methods: 64 elderly patients with hypertension admitted in our hospital from January 2019 to January 2021 were strictly selected as the key objects of this study. The department randomly divided them into two groups, the observation group and the control group, with 32 cases in each group. In terms of medication treatment, amlodipine and enalapril were used in the former group of patients with hypertension, and amlodipine tablets were used in the latter group. The changes of blood pressure, clinical indicators, incidence of adverse reactions, treatment effect, changes of serum inflammatory factors, improvement of quality of life and other research data of the two groups during the medication period were balanced into the statistical software for calculation.
文摘Urology has been on the forefront of technological advances in minimally invasive surgery, from laparoscopy to robot-assisted surgeries. As with all new technological advances in medicine, the results of new advances are compared to previously established gold standards. When it comes to robot-assisted urology, morbidity, oncological outcomes, and cost between the same surgeries performed in an open fashion vs with robot-assistance should be assessed. Because healthcare spending is increasingly under more scrutiny, there is debate on the cost effectiveness of robot-assisted surgeries given the high acquisition and maintenance cost of robotic systems. This articles aims to critically evaluate the cost effectiveness of robot-assisted surgeries for prostatectomies, cystectomies, and partial nephrectomies in the United States.
文摘背景与目的:多项回顾性研究显示,寡转移性前列腺癌根治术可以提高肿瘤的局部控制率和患者的总生存受益,围手术期并发症是影响寡转移性前列腺癌患者行前列腺癌根治术的一个重要因素。该研究旨在探讨寡转移性前列腺癌患者行前列腺癌根治术的临床初步疗效及围手术期并发症发生率和严重程度。方法:收集2015年7月—2016年1月247例前列腺癌根治术患者数据,其中寡转移性前列腺癌患者25例,局限性前列腺癌患者222例。两组均采用Clavien-Dindo手术并发症分级标准对出现并发症的患者进行分级。观察前列腺特异性抗原(prostate specific antigen,PSA)下降比例并将并发症发生率与严重程度在寡转移组和非寡转移组间进行对比分析。结果:寡转移组术后3个月时21例(84.0%)出现下降PSA,下降比例低于局限组212例(95.5%),差异有统计学意义(P<0.05)。寡转移组共6例(24.0%)患者发生术后并发症,其中严重并发症(Ⅲ度及以上)1例(4.0%),局限组共49例(22.1%)患者发生术后并发症,其中严重并发症(Ⅲ度及以上)7例(3.2%),差异无统计学意义(P>0.05)。结论:寡转移性前列腺癌患者行前列腺癌根治术治疗是安全、有效和可行的,并发症风险并非寡转移性前列腺癌患者行前列腺癌根治术的限制因素。
